264 related articles for article (PubMed ID: 19616668)
1. Comparison of olmesartan medoxomil versus amlodipine besylate on regression of ventricular and vascular hypertrophy.
Rosendorff C; Dubiel R; Xu J; Chavanu KJ
Am J Cardiol; 2009 Aug; 104(3):359-65. PubMed ID: 19616668
[TBL] [Abstract][Full Text] [Related]
2. Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.
Chrysant SG; Marbury TC; Silfani TN
Blood Press Monit; 2006 Jun; 11(3):135-41. PubMed ID: 16702822
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
[TBL] [Abstract][Full Text] [Related]
4. Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients.
Naya M; Tsukamoto T; Morita K; Katoh C; Furumoto T; Fujii S; Tamaki N; Tsutsui H
J Am Coll Cardiol; 2007 Sep; 50(12):1144-9. PubMed ID: 17868805
[TBL] [Abstract][Full Text] [Related]
5. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
6. Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: evaluation by baseline hypertension stage and prior antihypertensive medication use.
Oparil S; Lee J; Karki S; Melino M
J Cardiovasc Pharmacol; 2009 Nov; 54(5):427-36. PubMed ID: 19730391
[TBL] [Abstract][Full Text] [Related]
7. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
[TBL] [Abstract][Full Text] [Related]
8. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
Chrysant SG; Melino M; Karki S; Lee J; Heyrman R
Clin Ther; 2008 Apr; 30(4):587-604. PubMed ID: 18498909
[TBL] [Abstract][Full Text] [Related]
9. Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension.
Neutel JM; Smith DH; Silfani TN; Lee Y; Weber MA
J Hum Hypertens; 2006 Apr; 20(4):255-62. PubMed ID: 16397514
[TBL] [Abstract][Full Text] [Related]
10. Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study.
Lewin AJ; Kereiakes DJ; Chrysant SG; Izzo JL; Oparil S; Lee J; Fernandez V; Melino M
Ethn Dis; 2014; 24(1):41-7. PubMed ID: 24620447
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension.
Smolensky MH; Hermida RC; Portaluppi F
Chronobiol Int; 2007; 24(1):171-81. PubMed ID: 17364587
[TBL] [Abstract][Full Text] [Related]
12. Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial.
Takami T; Saito Y
Drug Des Devel Ther; 2013; 7():175-83. PubMed ID: 23662047
[TBL] [Abstract][Full Text] [Related]
13. The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy.
Hoshino A; Nakamura T; Matsubara H
Clin Exp Hypertens; 2010; 32(7):416-22. PubMed ID: 20828223
[TBL] [Abstract][Full Text] [Related]
14. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial.
Kloner RA; Neutel J; Roth EM; Weiss R; Weinberger MH; Thakker KM; Schwartz B; Shi H; Gregg AM;
Ann Pharmacother; 2008 Nov; 42(11):1552-62. PubMed ID: 18827176
[TBL] [Abstract][Full Text] [Related]
16. Effect of olmesartan medoxomil on cystatin C level, left ventricular hypertrophy and diastolic function.
Albayrak S; Ordu S; Ozhan H; Yazici M; Aydin M; Alemdar R; Kaya A
Blood Press; 2009; 18(4):187-91. PubMed ID: 19521888
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of population pharmacokinetics and exposure-response relationship with coadministration of amlodipine besylate and olmesartan medoxomil.
Rohatagi S; Carrothers TJ; Kshirsagar S; Khariton T; Lee J; Salazar D
J Clin Pharmacol; 2008 Jul; 48(7):823-36. PubMed ID: 18490496
[TBL] [Abstract][Full Text] [Related]
18. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
Rakić D; Rumboldt Z; Bagatin J; Polić S
Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure reduction with olmesartan in mild-to-moderate essential hypertension: a planned interim analysis of an open label sub-study in German patients.
Böhm M; Ewald S;
Curr Med Res Opin; 2006 Jul; 22(7):1375-80. PubMed ID: 16834836
[TBL] [Abstract][Full Text] [Related]
20. A review of the efficacy of fixed-dose combinations olmesartan medoxomil/hydrochlorothiazide and amlodipine besylate/benazepril in factorial design studies.
Quan A; Chavanu K; Merkel J
Am J Cardiovasc Drugs; 2006; 6(2):103-13. PubMed ID: 16555863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
